Skip to main content
Fig. 1 | Malaria Journal

Fig. 1

From: Assessing the safety, impact and effectiveness of RTS,S/AS01E malaria vaccine following its introduction in three sub-Saharan African countries: methodological approaches and study set-up

Fig. 1

Overview GSK’s RTS,S/AS01E vaccine post-approval plan embedded within the Malaria Vaccine Implementation Programme. AESIs adverse events of special interest, LSLV last subject last visit, MoH Ministry of Health, MVPE Malaria Vaccine Programme Evaluation, WHO World Health Organization, NRA National Regulatory Authority

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us